RU2019136633A3 - - Google Patents

Download PDF

Info

Publication number
RU2019136633A3
RU2019136633A3 RU2019136633A RU2019136633A RU2019136633A3 RU 2019136633 A3 RU2019136633 A3 RU 2019136633A3 RU 2019136633 A RU2019136633 A RU 2019136633A RU 2019136633 A RU2019136633 A RU 2019136633A RU 2019136633 A3 RU2019136633 A3 RU 2019136633A3
Authority
RU
Russia
Application number
RU2019136633A
Other languages
Russian (ru)
Other versions
RU2019136633A (ru
RU2759998C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2018/050506 external-priority patent/WO2018212708A1/en
Publication of RU2019136633A publication Critical patent/RU2019136633A/ru
Publication of RU2019136633A3 publication Critical patent/RU2019136633A3/ru
Application granted granted Critical
Publication of RU2759998C2 publication Critical patent/RU2759998C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
RU2019136633A 2017-05-17 2018-05-16 Лечение глаукомы RU2759998C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1750615 2017-05-17
SE1750615-5 2017-05-17
US201762555848P 2017-09-08 2017-09-08
US62/555,848 2017-09-08
PCT/SE2018/050506 WO2018212708A1 (en) 2017-05-17 2018-05-16 Treatment of glaucoma

Publications (3)

Publication Number Publication Date
RU2019136633A RU2019136633A (ru) 2021-06-17
RU2019136633A3 true RU2019136633A3 (https=) 2021-06-17
RU2759998C2 RU2759998C2 (ru) 2021-11-22

Family

ID=62245395

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019136633A RU2759998C2 (ru) 2017-05-17 2018-05-16 Лечение глаукомы

Country Status (12)

Country Link
US (1) US11291684B2 (https=)
EP (1) EP3532072B1 (https=)
JP (1) JP6817466B2 (https=)
KR (1) KR102331421B1 (https=)
CN (1) CN110621320B (https=)
CA (1) CA3063851C (https=)
DK (1) DK3532072T3 (https=)
ES (1) ES2777836T3 (https=)
IL (1) IL270362B (https=)
PL (1) PL3532072T3 (https=)
PT (1) PT3532072T (https=)
RU (1) RU2759998C2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3074987A1 (en) * 2017-09-08 2019-03-14 Tx Medic Ab New use of dextran sulfate
GB202008919D0 (en) * 2020-06-11 2020-07-29 Univ Birmingham Polysaccharide conpositions and therapeutic gels
CN115531417B (zh) * 2022-11-14 2024-04-09 青岛海尔生物科技有限公司 ITGA6阳性iPSC源小梁网类细胞在制备治疗高眼压疾病药物中的应用及筛选方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238482A (en) * 1978-09-29 1980-12-09 Peyman Gholam A Intraocular infusion irrigation solution and method
DE3705669A1 (de) 1987-02-21 1988-09-01 Thomae Gmbh Dr K Verwendung von dextransulfat zur herstellung eines arzneimittels zur behandlung und prophylaxe von gefaessverengungen und gefaessverschluessen
JPH02223525A (ja) * 1988-11-16 1990-09-05 Takeda Chem Ind Ltd 血管新生阻害剤
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
US5227372A (en) 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
CA2020199C (en) 1990-06-29 2002-08-20 Daniel Bar-Shalom Uses of sulphated sugars
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CA2331620A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
GB9917092D0 (en) 1999-07-22 1999-09-22 Ml Lab Plc Treatment of angiogenesis-dependent conditions
WO2005110438A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
SE0401182D0 (sv) 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
US20060154894A1 (en) 2004-09-15 2006-07-13 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
WO2007002139A2 (en) 2005-06-22 2007-01-04 The Trustees Of The University Of Pennsylvania Neuroprotection of retinal ganglion cells
US20140186339A1 (en) * 2006-10-27 2014-07-03 Lpath, Inc. Compositions and methods for treating ocular diseases and conditions
US20130273096A1 (en) 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
EP3142684A4 (en) * 2014-05-12 2018-05-23 Purdue Research Foundation Selectin and icam/vcam peptide ligand conjugates
WO2015190989A1 (en) 2014-06-12 2015-12-17 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
SE539575C2 (en) * 2015-07-30 2017-10-17 Tx Medic Ab Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis
CN107137421A (zh) 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Also Published As

Publication number Publication date
PL3532072T3 (pl) 2020-09-21
ES2777836T3 (es) 2020-08-06
EP3532072B1 (en) 2020-01-01
EP3532072A1 (en) 2019-09-04
KR102331421B1 (ko) 2021-11-25
CA3063851C (en) 2023-09-19
IL270362B (en) 2021-04-29
BR112019024087A2 (pt) 2020-06-02
CN110621320A (zh) 2019-12-27
JP2020519742A (ja) 2020-07-02
RU2019136633A (ru) 2021-06-17
RU2759998C2 (ru) 2021-11-22
KR20200005560A (ko) 2020-01-15
US20210315920A1 (en) 2021-10-14
PT3532072T (pt) 2020-03-05
US11291684B2 (en) 2022-04-05
CA3063851A1 (en) 2018-11-22
JP6817466B2 (ja) 2021-01-20
CN110621320B (zh) 2023-03-17
DK3532072T3 (da) 2020-04-06

Similar Documents

Publication Publication Date Title
BR122022025811B8 (https=)
RU2019136633A3 (https=)
BR202018014992U2 (https=)
BR122022003520A2 (https=)
BR202017025154U2 (https=)
BR202017021228U2 (https=)
BR202017020981U2 (https=)
BR202017017068U2 (https=)
BR202017016984U2 (https=)
BR202017016924U2 (https=)
BR202017012548U2 (https=)
BR202017011220U2 (https=)
BR202017010814U2 (https=)
BR202017010373U2 (https=)
BR202017009870U2 (https=)
BR202017006953U2 (https=)
BR202017004898U2 (https=)
BR202017002937U2 (https=)
BR202017002826U2 (https=)
CN304004514S (https=)
CN303826083S9 (https=)
CN303949240S9 (https=)
CN304003970S (https=)
CN304005888S (https=)
CN304008517S (https=)